BioNexus Gene Lab Corp Annual Cost of Revenue in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
BioNexus Gene Lab Corp quarterly/annual Cost of Revenue history and growth rate from 2018 to 2024.
  • BioNexus Gene Lab Corp Cost of Revenue for the quarter ending December 31, 2024 was $2.21M, a 10.4% increase year-over-year.
  • BioNexus Gene Lab Corp Cost of Revenue for the twelve months ending December 31, 2024 was $8.22M, a 2.61% decline year-over-year.
  • BioNexus Gene Lab Corp annual Cost of Revenue for 2024 was $8.22M, a 2.61% decline from 2023.
  • BioNexus Gene Lab Corp annual Cost of Revenue for 2023 was $8.44M, a 12.7% decline from 2022.
  • BioNexus Gene Lab Corp annual Cost of Revenue for 2022 was $9.67M, a 12.9% decline from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $8.22M -$220K -2.61% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 $8.44M -$1.23M -12.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 $9.67M -$1.43M -12.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $11.1M +$1.43M +14.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $9.67M +$9.6M +13508% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-06
2019 $71.1K +$255K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 -$184K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.